Skip to content
Thursday, December 18, 2025

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Liberal Zionist groups criticize Trump administration’s travel ban on those with Palestinian Authority passports December 18, 2025
  • Forging Israel’s quiet heroes: Inside the Holtz Air Force High School December 18, 2025
  • Judaism’s Conservative movement apologizes for decades of discouraging intermarriage, signals new approach December 18, 2025
  • As Australian Jews call for action on antisemitism, contrite PM unveils moves to curb hate speech December 18, 2025
  • Celebrating Hanukkah with Hindsight Generated by the Hasmoneans December 18, 2025
  • Ben Shapiro denounces Tucker Carlson at Heritage, urges policing of conservative movement December 17, 2025

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.